Literature DB >> 17560557

Regional dissection and determination of loosely bound and non-heme iron in the developing mouse brain.

Shino Magaki1, Claudius Mueller, Steven M Yellon, James Fox, Joseph Kim, Eugene Snissarenko, Vernon Chin, Manik C Ghosh, Wolff M Kirsch.   

Abstract

Iron is a trace metal essential for normal brain development but toxic in excess as it is capable of generating highly reactive radicals that damage cells and tissue. Iron is stringently regulated by the iron regulatory proteins, IRP1 and IRP2, which regulate proteins involved in iron homeostasis at the posttranscriptional level. In this study, 12 distinct regions were microdissected from the mouse brain and regional changes in the levels of loosely bound and non-heme iron that occur with development were measured. We examined 6, 12, and 24 week old wildtype C57BL/6 mice and mice with a targeted deletion of iron regulatory protein 2 (IRP2-/-) that have been reported to develop neurodegenerative symptoms in adulthood. In wildtype mice, levels of loosely bound iron decreased while non-heme iron increased with development. In contrast, an increase in loosely bound and a more pronounced increase in non-heme iron was seen in IRP2-/- mice between 6 and 12 weeks of age, stemming from lower levels at 6 weeks (the youngest age examined) compared to wildtype. These results have implications for understanding the increase in regional brain iron that is associated with normal aging and is postulated to be exacerbated in neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17560557      PMCID: PMC1959335          DOI: 10.1016/j.brainres.2007.05.004

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  37 in total

Review 1.  A brief history of brain iron research.

Authors:  Arnulf H Koeppen
Journal:  J Neurol Sci       Date:  2003-03-15       Impact factor: 3.181

2.  Intracellular labile iron pools as direct targets of iron chelators: a fluorescence study of chelator action in living cells.

Authors:  Hava Glickstein; Rinat Ben El; Maya Shvartsman; Z Ioav Cabantchik
Journal:  Blood       Date:  2005-07-14       Impact factor: 22.113

Review 3.  Molecular control of vertebrate iron homeostasis by iron regulatory proteins.

Authors:  Michelle L Wallander; Elizabeth A Leibold; Richard S Eisenstein
Journal:  Biochim Biophys Acta       Date:  2006-05-17

4.  Iron homeostasis in the brain: complete iron regulatory protein 2 deficiency without symptomatic neurodegeneration in the mouse.

Authors:  Bruno Galy; Sabine M Hölter; Thomas Klopstock; Dunja Ferring; Lore Becker; Sylvia Kaden; Wolfgang Wurst; Hermann-Josef Gröne; Matthias W Hentze
Journal:  Nat Genet       Date:  2006-09       Impact factor: 38.330

5.  Age-related changes in iron homeostasis and cell death in the cerebellum of ceruloplasmin-deficient mice.

Authors:  Suh Young Jeong; Samuel David
Journal:  J Neurosci       Date:  2006-09-20       Impact factor: 6.167

6.  Iron, transferrin, and ferritin in the rat brain during development and aging.

Authors:  A J Roskams; J R Connor
Journal:  J Neurochem       Date:  1994-08       Impact factor: 5.372

7.  Severity of neurodegeneration correlates with compromise of iron metabolism in mice with iron regulatory protein deficiencies.

Authors:  Sophia R Smith; Sharon Cooperman; Tim Lavaute; Nancy Tresser; Manik Ghosh; Esther Meyron-Holtz; William Land; Hayden Ollivierre; Bernard Jortner; Robert Switzer; Albee Messing; Tracey A Rouault
Journal:  Ann N Y Acad Sci       Date:  2004-03       Impact factor: 5.691

8.  Genetic and behavioral differences among five inbred mouse strains commonly used in the production of transgenic and knockout mice.

Authors:  G W M Bothe; V J Bolivar; M J Vedder; J G Geistfeld
Journal:  Genes Brain Behav       Date:  2004-06       Impact factor: 3.449

9.  MRI detection of ferritin iron overload and associated neuronal pathology in iron regulatory protein-2 knockout mice.

Authors:  Colette Grabill; Afonso C Silva; Sophia S Smith; Alan P Koretsky; Tracey A Rouault
Journal:  Brain Res       Date:  2003-05-02       Impact factor: 3.252

Review 10.  Neurodegenerative diseases and oxidative stress.

Authors:  Kevin J Barnham; Colin L Masters; Ashley I Bush
Journal:  Nat Rev Drug Discov       Date:  2004-03       Impact factor: 84.694

View more
  7 in total

Review 1.  Iron misregulation and neurodegenerative disease in mouse models that lack iron regulatory proteins.

Authors:  Manik C Ghosh; De-Liang Zhang; Tracey A Rouault
Journal:  Neurobiol Dis       Date:  2015-03-11       Impact factor: 5.996

2.  Changing iron content of the mouse brain during development.

Authors:  Gregory P Holmes-Hampton; Mrinmoy Chakrabarti; Allison L Cockrell; Sean P McCormick; Louise C Abbott; Lora S Lindahl; Paul A Lindahl
Journal:  Metallomics       Date:  2012-07-19       Impact factor: 4.526

3.  Altered serum iron and copper homeostasis predicts cognitive decline in mild cognitive impairment.

Authors:  Claudius Mueller; Matthew Schrag; Andrew Crofton; Jens Stolte; Martina U Muckenthaler; Shino Magaki; Wolff Kirsch
Journal:  J Alzheimers Dis       Date:  2012       Impact factor: 4.472

4.  Low-molecular-mass metal complexes in the mouse brain.

Authors:  Sean P McCormick; Mrinmoy Chakrabarti; Allison L Cockrell; Jinkyu Park; Lora S Lindahl; Paul A Lindahl
Journal:  Metallomics       Date:  2013-03       Impact factor: 4.526

5.  Loss of divalent metal transporter 1 function promotes brain copper accumulation and increases impulsivity.

Authors:  Murui Han; JuOae Chang; Jonghan Kim
Journal:  J Neurochem       Date:  2016-07-22       Impact factor: 5.372

6.  Iron regulatory protein 2 is involved in brain copper homeostasis.

Authors:  Claudius Mueller; Shino Magaki; Matthew Schrag; Manik C Ghosh; Wolff M Kirsch
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

7.  Targeting the progression of Parkinson's disease.

Authors:  J L George; S Mok; D Moses; S Wilkins; A I Bush; R A Cherny; D I Finkelstein
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.